Evidence map›Paper›PMID 31798476›Full record

ArticleFrontiers in psychiatry2019

Association of rs4680

Anna Morozova, Yana Zorkina, Konstantin Pavlov, Olga Pavlova, Zinaida Storozheva, Eugene Zubkov, Natalia Zakharova, Olga Karpenko, Alexander Reznik, Vladimir Chekhonin and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Anna MorozovaDepartment Basic and Applied Neurobiology, V. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Moscow, Russia.
Yana ZorkinaDepartment Basic and Applied Neurobiology, V. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Moscow, Russia.
Konstantin PavlovDepartment Basic and Applied Neurobiology, V. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Moscow, Russia.
Olga PavlovaDepartment Basic and Applied Neurobiology, V. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Moscow, Russia.
Zinaida StorozhevaDepartment Basic and Applied Neurobiology, V. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Moscow, Russia.
Eugene ZubkovDepartment Basic and Applied Neurobiology, V. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Moscow, Russia.
Natalia ZakharovaN.A. Alekseev Psychiatric Clinical Hospital № 1, Moscow, Russia.
Olga KarpenkoN.A. Alekseev Psychiatric Clinical Hospital № 1, Moscow, Russia.
Alexander ReznikN.A. Alekseev Psychiatric Clinical Hospital № 1, Moscow, Russia.
Vladimir ChekhoninDepartment Basic and Applied Neurobiology, V. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Moscow, Russia.
Georgiy KostyukN.A. Alekseev Psychiatric Clinical Hospital № 1, Moscow, Russia.
Federal Medical Research Centre for Psychiatry and Narcology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the associations of rs4680

Indexed as

5-hydroxytryptamine 2A receptorscatechol-O-methyltransferasedopamine receptor D3schizophreniasingle-nucleotide polymorphismyouth-onset

Identifiers

PMID31798476
PMCPMC6863060
OpenAlexW2987864881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.